Inhibitory monoaminooksydazy (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Inhibitory monoaminooksydazy" in Polish language version.

refsWebsite
Global rank Polish rank
2nd place
6th place
4th place
7th place
3,823rd place
low place
5th place
2nd place
low place
low place
low place
low place
low place
low place
low place
low place
low place
low place
low place
low place
low place
low place
5,564th place
low place
low place
low place
low place
low place
low place
low place
low place
low place
low place
low place
447th place
1,118th place
low place
low place
low place
low place
low place
low place
234th place
204th place
low place
low place
low place
low place

apollopharmacy.in

aristo-pharma.de

canadapharmacyonline.com

doi.org

dx.doi.org

  • I.J. Selikoff, E.H. Robitzek, Tuberculosis chemotherapy with hydrazine derivatives of isonicotinic acid, „Diseases of the Chest”, 21 (4), 1952, s. 385–438, DOI10.1378/chest.21.4.385, PMID14906149 (ang.).
  • R.V. Rangle, The Antihypertensive and Hypoglycemic Effects of Pargyline Hydrochloride, „Angiology”, 16, 1965, s. 351–354, DOI10.1177/000331976501600608, PMID14294431 (ang.).
  • G.L. Gessa, E. Cuenca, E. Costa, On the mechanism of hypotensive effects of MAO inhibitors, „Annals of the New York Academy of Sciences”, 107, 1963, s. 935–944, DOI10.1111/j.1749-6632.1963.tb13336.x, PMID13947412 (ang.).
  • Cameron Kiani, Tranylcypromine: Its Pharmacology, Safety, and Efficacy, „American Journal of Psychiatry Residents' Journal”, 15 (4), 2020, s. 3–5, DOI10.1176/appi.ajp-rj.2020.150402 (ang.).
  • M. Philipp, R. Kohnen, O. Benkert, A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction, „International Clinical Psychopharmacology”, 7 (3-4), 1993, s. 149–153, DOI10.1097/00004850-199300730-00005, PMID8468436 (ang.).
  • Alessandro Serretti, Alberto Chiesa, Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis, „Journal of Clinical Psychopharmacology”, 29 (3), 2009, s. 259–266, DOI10.1097/JCP.0b013e3181a5233f, PMID19440080 (ang.).
  • E.D. West, P.J. Dally, Effects of Iproniazid in Depressive Syndromes, „British Medical Journal”, 1 (5136), 1959, s. 1491–1494, DOI10.1136/bmj.1.5136.1491, PMID13651775, PMCIDPMC1993720 (ang.).
  • Lina Chiuccariello i inni, Elevated Monoamine Oxidase A Binding During Major Depressive Episodes Is Associated with Greater Severity and Reversed Neurovegetative Symptoms, „Neuropsychopharmacology”, 39 (4), 2014, s. 973–980, DOI10.1038/npp.2013.297, PMID24154665, PMCIDPMC3924531 (ang.).
  • Peter Riederer, Gerd Laux, MAO-inhibitors in Parkinson's Disease, „Experimental Neurobiology”, 20 (1), 2011, s. 1–17, DOI10.5607/en.2011.20.1.1, PMID22110357, PMCIDPMC3213739 (ang.).

efarma.nl

farmacotherapeutischkompas.nl

  • Zorginstituut Nederland, tranylcypromine [online], www.farmacotherapeutischkompas.nl [dostęp 2023-01-07] (niderl.).

fda.gov

accessdata.fda.gov

gelbe-liste.de

geneesmiddeleninformatiebank.nl

gov.br

helsedirektoratet.no

  • Tranylcypromine [online], Helsedirektoratet [dostęp 2023-01-07] (norw.).

hres.ca

pdf.hres.ca

indlaegssedler.dk

marplan.com

medicijnkosten.nl

medicines.ie

medicines.org.uk

medsafe.govt.nz

mozdocs.kiev.ua

nature.com

nih.gov

ncbi.nlm.nih.gov

  • I.J. Selikoff, E.H. Robitzek, Tuberculosis chemotherapy with hydrazine derivatives of isonicotinic acid, „Diseases of the Chest”, 21 (4), 1952, s. 385–438, DOI10.1378/chest.21.4.385, PMID14906149 (ang.).
  • R.V. Rangle, The Antihypertensive and Hypoglycemic Effects of Pargyline Hydrochloride, „Angiology”, 16, 1965, s. 351–354, DOI10.1177/000331976501600608, PMID14294431 (ang.).
  • G.L. Gessa, E. Cuenca, E. Costa, On the mechanism of hypotensive effects of MAO inhibitors, „Annals of the New York Academy of Sciences”, 107, 1963, s. 935–944, DOI10.1111/j.1749-6632.1963.tb13336.x, PMID13947412 (ang.).
  • M.H. Kronig i inni, Blood pressure effects of phenelzine, „Journal of Clinical Psychopharmacology”, 3 (5), 1983, s. 307–310, PMID6630590 (ang.).
  • M. Philipp, R. Kohnen, O. Benkert, A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction, „International Clinical Psychopharmacology”, 7 (3-4), 1993, s. 149–153, DOI10.1097/00004850-199300730-00005, PMID8468436 (ang.).
  • Alessandro Serretti, Alberto Chiesa, Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis, „Journal of Clinical Psychopharmacology”, 29 (3), 2009, s. 259–266, DOI10.1097/JCP.0b013e3181a5233f, PMID19440080 (ang.).
  • E.D. West, P.J. Dally, Effects of Iproniazid in Depressive Syndromes, „British Medical Journal”, 1 (5136), 1959, s. 1491–1494, DOI10.1136/bmj.1.5136.1491, PMID13651775, PMCIDPMC1993720 (ang.).
  • Lina Chiuccariello i inni, Elevated Monoamine Oxidase A Binding During Major Depressive Episodes Is Associated with Greater Severity and Reversed Neurovegetative Symptoms, „Neuropsychopharmacology”, 39 (4), 2014, s. 973–980, DOI10.1038/npp.2013.297, PMID24154665, PMCIDPMC3924531 (ang.).
  • Peter Riederer, Gerd Laux, MAO-inhibitors in Parkinson's Disease, „Experimental Neurobiology”, 20 (1), 2011, s. 1–17, DOI10.5607/en.2011.20.1.1, PMID22110357, PMCIDPMC3213739 (ang.).

northwestpharmacy.com

vidal.ru

worldcat.org

  • Robert A. Maxwell, Drug discovery : a casebook and analysis, Clifton, N.J.: Humana Press, 1990, ISBN 0-89603-180-2, OCLC 21910579 [dostęp 2023-01-07].
  • Stephen M. Stahl, Case studies : Stahl's essential psychopharmacology, Cambridge, UK: Cambridge University Press, 2011, ISBN 978-0-521-18208-9, OCLC 698331451 [dostęp 2023-01-07].